The researchers emphasized ... Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three ...
More than half of the world’s population may be overweight or have obesity by 2035, and slowing this trend with weight loss drugs could have enormous impacts on public health. But while ...
Shares of BioAge Labs plunged nearly 70% in premarket trading Monday after the clinical-stage biopharmaceutical company said it was ending a mid-stage study of its lead program, a proposed obesity ...